Fresenius Medical Care names Shervin Korangy as new CEO

Go back to Fresenius Medical Care names Shervin Korangy as new CEO

Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth

October 7, 2026 11:28 AM EDT

BAD HOMBURG, Germany, Oct. 7, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced that Shervin J. Korangy (51) will become Chief Executive Officer (CEO) and Chair of the Management Board, effective October 12, 2026. The Supervisory Board unanimously appointed him to succeed Helen Giza (58), who has served as CEO and Chair of the Management Board for four years, following three years as... More